TradingView
trademan1
Feb 27, 2015 6:48 PM

CYCC Oversold Previously, Now Everyone's Buying Long

NASDAQ:CYCC1D
Cyclacel Pharmaceuticals, Inc.NASDAQ

Description

⋅
It gapped down in the past because they dropped one of their studies but the company has many other products in development. There are messages that the float has been bought up and funds and insiders are buying heavily for some event.
Bullish Patternsoversoldcyclacelpharmaceuticalsfundsinsidersbuyingfloat
More